What is Enliven Therapeutics's capex?

Enliven Therapeutics (ELVN) reported capex of $0 in Q1 2026.

How has Enliven Therapeutics's capex changed year-over-year?

Enliven Therapeutics's capex decreased by 100.0% year-over-year, from $20K to $0.

What is the long-term trend for Enliven Therapeutics's capex?

Over 2 years (2022 to 2024), Enliven Therapeutics's capex has grown at a -73.2% compound annual growth rate (CAGR), from $612K to $44K.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Enliven Therapeutics ELVN CapEx

CapEx at other companies

Bristol-Myers SquibbBMY

$347M+33.5%

PfizerPFE

$436M-22.7%

Relay Therapeutics, Inc.RLAY

$1K—

Arcus BiosciencesRCUS

$0-100%

Intellia TherapeuticsNTLA

$79K-89.3%

ImmunityBio, Inc.IBRX

$1.78M+58.4%

Other financials

Income statement

See full

Operating income-$27.8M+12.2%

Net income-$23.6M+17.2%

EPS (diluted)-$0.38+33.3%

Balance sheet

See full

Cash & equivalents$132.2M+30.0%

Total debt$302.0K-56.9%

Total equity$453.4M+57.3%

Total assets$464.9M+53.6%

Cash flow

See full

Operating cash flow-$19.3M+20.0%

Free cash flow-$19.3M+20.1%

Valuation

See full

Market cap$3.47B+143%

Enterprise value$3.34B+156%

Returns & leverage

See full

Return on equity-26.6%-3.5pp

Debt / equity0×0.0×

Current ratio40.3×+19.3×

Where this comes from

Reported directly by Enliven Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireProductiveAssets.

The official record: Enliven Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enliven Therapeutics's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Enliven Therapeutics's capex?: Enliven Therapeutics (ELVN) reported capex of $0 in Q1 2026.
How has Enliven Therapeutics's capex changed year-over-year?: Enliven Therapeutics's capex decreased by 100.0% year-over-year, from $20K to $0.
What is the long-term trend for Enliven Therapeutics's capex?: Over 2 years (2022 to 2024), Enliven Therapeutics's capex has grown at a -73.2% compound annual growth rate (CAGR), from $612K to $44K.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.